中國的寵物用動物健康市場

China Companion Animal Health Market - 2019-2026

出版日期: 2020年01月01日 | 出版商:

DataM Intelligence | 英文 | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

全貌
簡介
目錄

簡介

本報告提供中國的寵物用的動物健康的相關市場相關分析，市場基本結構和最新形勢，整體市場趨勢預測 (今後8年份)，各產品、動物詳細趨勢，主要的推動及阻礙市場要素，市場佔有率結構，主要企業的簡介等相關調查。

第1章中國的寵物用動物健康市場:分析方法、範圍

第2章中國的寵物用動物健康市場:趨勢

主要趨勢和動靜

第3章中國的寵物用動物健康市場:產業分析

推動市場要素
阻礙市場要素
市場競爭的密度:波特的五力分析

第4章中國的寵物用動物健康市場:各產品

疫苗
抗感染疾病藥
醫療用飼料添加物
寄生蟲驅除劑
診斷藥
其他

第5章中國的寵物用動物健康市場:各動物

貓
狗
馬
其他

第6章中國的寵物用動物健康市場:競爭環境

企業分析
主要製造商採用的策略

第7章中國的寵物用動物健康市場:企業簡介

MSD Animal Health China (Merck)
Ceva Sante Animale
Bayer Healthcare
Virbac
Boehringer Ingelheim
Zoetis
Elanco
China Animal Healthcare Ltd
Ringpu
Zhejiang Shenghua Biok Biology Co Ltd

第8章附錄

China Companion Animal Health Market Overview

Companion animals are pets which are kept for protection of a person, company, property or residence. These animals help to avoid theft and render safe environment. Dog and cats are the most popular pets. Companion animals play an important role in the lives of many, providing a sense of belonging and responsibility. Animal health products, especially feeds are the most widely used products for animal healthcare.

China companion animal health market was worth USD XX million in 2017 and is forecasted to reach USD 1339.50 million by 2025, growing at a CAGR of XX% during the forecast period (2018-2025).

China Companion Animal Health Market - Market Dynamics

Pet ownership is on the rise in China, which has led to increased demand for veterinary care. Owners have become more conscious about the health and well-being of their pets. There are around 1.1 million animal clinics in China, 70% are family-run practices, and the rest are mostly small medical institutions. According to China's National Bureau of Statistics, China ranked third in the world in terms of ownership of pet dogs, at over 27 million. It is also second in global cat ownership, with 58.1 million cats reported. The two largest cities Shanghai and Beijing of China account for much of that pet ownership, with 24% of Shanghai's residents owning dogs and 11% owning cats. 25% of Beijing residents own dogs, while 8% own cats.

On the other side, The high cost of veterinary for animals and animal testing might be a barrier to the growth of the market. There are several restrictions and regulations on animal testing in China, which is hindering a number of healthcare companies from manufacturing newly advanced drugs. Also, because of the increasing regulations, animal testing is becoming expensive. The cost of veterinary medicines and products have also increased manifold in the recent years, which is making the animal ownership expensive and unfeasible for the middle-class.

China Companion Animal Health Market - Segment Analysis

China companion animal health market is categorized by various types of products such as Vaccines, Anti-Infectives, Medicinal Feed Additives, Parasiticides, Diagnostic and Others. Of these, paraciticides accounted for the largest market share of about in 2017. Demand for parasiticides is also on the rise because of an increase in flea and tick-infested Lyme disease in dogs and cats. Medicinal Feed Additives provide vital protection against disease-causing pathogen agents like bacteria, viruses, and fungi without involving the side-effects associated with vaccines and anti-infectives. The market is driven by the need for these products in tackling the increasing cases of healthcare problems in companion animals and awareness of owners towards the availability of these products in commercial markets.

China Companion Animal Health Market - Competitive Analysis

Chinese companion animal health market is fragmented with presence of many local and international players. However, Boehringer Ingelheim, Zoetis, Bayer Healthcare, MSD Animal Health (Merck), and Virbac holds major market share in the global companion animal health market. Elanco, Ceva Sante Animale, Ringpu, Bionik, and China Animal Healthcare Ltd. are the other prominent players in the market. Boehringer Ingelheim is the market leader with approximately 20% of the total market followed by Zeotis, Bayer Healthcare, and MSD Animal Health (Merck). Boehringer Ingelheim is became a market leader with the acquisition of Sanofi's animal-health business (Merial). The acquisition of Merial makes Boehringer Ingelheim the second-largest animal health company in the world. The U.S. animal-health market will be the largest for Boehringer Ingelheim, representing about 40% of annual sales.

Why purchase the report?

Visualize the composition of the china companion animal health market products across each indication, in terms of products types, and animals highlighting the critical commercial assets and players.
Identify commercial opportunities in the companion animal health products market by analyzing trends and co-development deals.
Excel data sheet with thousands of data points of the companion animal health products levels 4/5 segmentation.
PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
Product mapping in excel for the essential companion animal health products of all major market players.

Target Audience